Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah M Anderson

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of the American Mosquito Control Association|March 13, 2026
MULTI-COUNTY TICK SURVEY (ACARI: IXODIDAE) IN MISSOURI USA, 2019 AND 2021Patricia J Norton, Samniqueka J Halsey, Kendall Mara, et al.
Viruses|July 29, 2023
Equine Polyclonal Antibodies Prevent Acute Chikungunya Virus Infection in MiceDouglas Barker, Xiaobing Han, Eryu Wang, et al.
Infection and Immunity|July 25, 2006
Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrVKristin L DeBord, Deborah M Anderson, Melanie M Marketon, et al.
Antimicrobial Agents and Chemotherapy|February 28, 2023
Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 StudySean T H Liu, Mila Mirceta, Grace Lin, et al.
Plos One|July 16, 2015
Resistance to Innate Immunity Contributes to Colonization of the Insect Gut by Yersinia pestisShaun C Earl, Miles T Rogers, Jennifer Keen, et al.
The American Journal of Pathology|January 24, 2009
Pneumonic plague pathogenesis and immunity in Brown Norway ratsDeborah M Anderson, Nancy A Ciletti, Hanni Lee-Lewis, et al.
Lancet (London, England)|March 30, 2025
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trialLauren C Tindale, Jason S Richardson, Deborah M Anderson, et al.
Lancet (London, England)|March 30, 2025
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trialJason S Richardson, Deborah M Anderson, Jason Mendy, et al.
NPJ Vaccines|January 6, 2026
Passive transfer of human sera from chikungunya virus virus-like particle vaccine (Vimkunya) recipients fully protects non-human primates from viremiaChristopher S Morello, Ravi Anantha, Jason E Comer, et al.
Plos One|July 14, 2022
Human immune globulin treatment controls Zika viremia in pregnant rhesus macaquesDawn M Dudley, Michelle R Koenig, Laurel M Stewart, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of the American Mosquito Control Association|March 13, 2026
MULTI-COUNTY TICK SURVEY (ACARI: IXODIDAE) IN MISSOURI USA, 2019 AND 2021Patricia J Norton, Samniqueka J Halsey, Kendall Mara, et al.
Viruses|July 29, 2023
Equine Polyclonal Antibodies Prevent Acute Chikungunya Virus Infection in MiceDouglas Barker, Xiaobing Han, Eryu Wang, et al.
Infection and Immunity|July 25, 2006
Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrVKristin L DeBord, Deborah M Anderson, Melanie M Marketon, et al.
Antimicrobial Agents and Chemotherapy|February 28, 2023
Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 StudySean T H Liu, Mila Mirceta, Grace Lin, et al.
Plos One|July 16, 2015
Resistance to Innate Immunity Contributes to Colonization of the Insect Gut by Yersinia pestisShaun C Earl, Miles T Rogers, Jennifer Keen, et al.
The American Journal of Pathology|January 24, 2009
Pneumonic plague pathogenesis and immunity in Brown Norway ratsDeborah M Anderson, Nancy A Ciletti, Hanni Lee-Lewis, et al.
Lancet (London, England)|March 30, 2025
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trialLauren C Tindale, Jason S Richardson, Deborah M Anderson, et al.
Lancet (London, England)|March 30, 2025
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trialJason S Richardson, Deborah M Anderson, Jason Mendy, et al.
NPJ Vaccines|January 6, 2026
Passive transfer of human sera from chikungunya virus virus-like particle vaccine (Vimkunya) recipients fully protects non-human primates from viremiaChristopher S Morello, Ravi Anantha, Jason E Comer, et al.
Plos One|July 14, 2022
Human immune globulin treatment controls Zika viremia in pregnant rhesus macaquesDawn M Dudley, Michelle R Koenig, Laurel M Stewart, et al.
Pageof 5